Physician profile

Michelle Ds Lightfoot

Obstetrics & Gynecology · Boston, MA

NPI 1699189910

$23,460.94

in general payments reported to CMS, 2019-2025

6 companies · $4,237 in 2025

The $4,237 reported for 2025 was more than what 96% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).

See the full distribution for Obstetrics & Gynecology

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Consulting Fee$19,795.00
Travel and Lodging$2,788.49
Food and Beverage$812.07

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Glaxosmithkline, LLC. $21,428.16 2023-2025 Jemperli
Merck Sharp & Dohme LLC $1,898.29 2024-2025
Seagen INC. $65.38 2022
Medtronic, INC. $24.09 2025 Signia
Abbvie INC. $23.86 2024
Hologic Sales and Service, LLC $21.16 2023 Coolseal Generator

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Michelle Ds Lightfoot

$23,460.94

in general payments reported 2019-2025

Years
2022-2025
Top company
Glaxosmithkline, LLC.
Context
The $4,237 reported for 2025 was more than what 96% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).

https://glasscript.com/doctor/866522/michelle-ds-lightfoot

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.